United States · FDA National Drug Code directory
medroxyprogesterone acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70121-1467_391fd062-e255-4396-aaff-027344c3a39d
- Product NDC
- 70121-1467
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- medroxyprogesterone acetate
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230613
- Source listing expiry
- 20271231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70121-1467-2) / 1 mL in 1 VIAL · 70121-1467-2
- 25 VIAL in 1 CARTON (70121-1467-5) / 1 mL in 1 VIAL · 70121-1467-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →